A carregar...
A qualitative assessment of the challenges of WHO prequalification for anti-malarial drugs in China
BACKGROUND: While China is a major manufacturer of artemisinin and its derivatives, it lags as a global leader in terms of the total export value of anti-malarial drugs as finished pharmaceutical products ready for marketing and use by patients. This may be due to the limited number of World Health...
Na minha lista:
| Publicado no: | Malar J |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5883522/ https://ncbi.nlm.nih.gov/pubmed/29615066 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-018-2303-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|